ArticleCell death and differentiation2021

Loss of desmoglein-2 promotes gallbladder carcinoma progression and resistance to EGFR-targeted therapy through Src kinase activation.

Sang-Hyun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.